Table 3 Correlation analysis of risk factors with the prognosis of patients with drug eruption.

From: Clinical analysis of HIV/AIDS patients with drug eruption in Yunnan, China

Risk factor

 

Drug eruption group (n = 134)

P value

Cured/improved cases (n = 124)

Death cases (n = 10)

Sex

Male

83 (93.3)

6 (6.7)

0.679

 

Female

41 (91.1)

4 (8.9)

 

Age

≤50

98 (92.5)

8 (7.5)

0.942

 

>50

26 (92.9)

2 (7.1)

 

Allergic history

Yes

16 (76.2)

5 (23.8)

0.008a

 

No

108 (95.6)

5 (4.4)

 

Opportunistic infection

Yes

72 (77.8)

10 (12.2)

0.009a

 

No

52 (100.0)

0 (0.0)

 

HAART

Yes

78 (95.1)

4 (4.9)

0.153

 

No

46 (88.5)

6 (11.5)

 

Sensitization route

Intravenous

38 (88.4)

5 (11.6)

0.363

 

Oral

86 (94.5)

5 (5.5)

 

Fever

Yes

43 (93.0)

4 (7.0)

1.000

 

No

81 (92.2)

6 (7.8)

 

Lymphadenectasis

Yes

7 (87.5)

1 (12.5)

0.472b

 

No

117 (92.9)

9 (7.1)

 

Viral load

Median ± IRc

1950.00 ± 288700.00

440000.00 ± 1917225.00

0.008a

CD4+ T cell count

Median ± IR

157.50 ± 219.25

41.50 ± 122.25

0.021a

t-Bil

Median ± IR

8.70 ± 8.70

12.30 ± 10.40

0.400

AST

Median ± IR

45.00 ± 69.25

44.00 ± 32.00

1.000

ALT

Median ± IR

42.50 ± 87.00

39.00 ± 86.25

0.684

ALB

Median ± IR

36.15 ± 6.35

31.35 ± 13.00

0.002a

GLB

Median ± IR

29.95 ± 8.33

29.05 ± 8.60

0.694

CREA

Median ± IR

63.00 ± 20.00

59.80 ± 40.50

0.531

BUN

Median ± IR

3.60 ± 2.25

5.75 ± 4.37

0.192

WBC

Median ± IR

3.97 ± 2.53

3.15 ± 1.83

0.041a

NEU

Median ± IR

2.42 ± 2.10

1.95 ± 1.49

0.207

LYM

Median ± IR

1.00 ± 0.85

0.80 ± 0.47

0.109

RBC

Mean ± SD

4.00 ± 0.67

3.31 ± 0.60

0.002a

Hb

Mean ± SD

121.54 ± 18.25

98.10 ± 18.53

<0.001a

PLT

Mean ± SD

166.62 ± 74.60

148.00 ± 72.21

0.448

EOS

Median ± IR

0.10 ± 0.22

0.11 ± 0.45

0.760

  1. aP < 0.05.
  2. bFisher’s exact test.
  3. cIR = interquartile range.